A Multicenter, Randomized, Double-blind, Double-dummy, 2-period Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects

Trial Profile

A Multicenter, Randomized, Double-blind, Double-dummy, 2-period Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Sep 2015

At a glance

  • Drugs Lacosamide (Primary) ; Carbamazepine
  • Indications Epilepsy; Essential tremor; Fibromyalgia; Osteoarthritis; Pain; Sleep disorders; Tonic-clonic epilepsy
  • Focus Therapeutic Use
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 20 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology (AAN), according to a UCB media release.
    • 23 Jan 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 28 Oct 2013 Planned End Date changed from 1 Oct 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top